CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 39 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $38,000 | -33.3% | 165,600 | 0.0% | 0.01% | -44.4% |
| Q4 2017 | $57,000 | -54.8% | 165,600 | -1.2% | 0.01% | -52.6% |
| Q3 2017 | $126,000 | +27.3% | 167,600 | +0.3% | 0.02% | +18.8% |
| Q2 2017 | $99,000 | -65.5% | 167,100 | -5.1% | 0.02% | -69.2% |
| Q1 2017 | $287,000 | +21.6% | 176,100 | -4.3% | 0.05% | +13.0% |
| Q4 2016 | $236,000 | +14.0% | 184,100 | -5.0% | 0.05% | +9.5% |
| Q3 2016 | $207,000 | +11.3% | 193,800 | +8.5% | 0.04% | +10.5% |
| Q2 2016 | $186,000 | -13.5% | 178,550 | +0.6% | 0.04% | -20.8% |
| Q1 2016 | $215,000 | +53.6% | 177,550 | +95.5% | 0.05% | +54.8% |
| Q4 2015 | $140,000 | -22.7% | 90,800 | +4.7% | 0.03% | -32.6% |
| Q3 2015 | $181,000 | +162.3% | 86,700 | +542.2% | 0.05% | +187.5% |
| Q2 2015 | $69,000 | – | 13,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 1,132,737 | $1,399,000 | 0.21% |
| Prospera Financial Services Inc | 177,550 | $215,000 | 0.05% |
| LBA Wealth Management, LLC | 12,000 | $15,000 | 0.01% |
| Cambridge Investment Research Advisors, Inc. | 23,457 | $28,000 | 0.00% |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 313,801 | $866,000 | 0.00% |
| TEACHERS ADVISORS, LLC | 148,551 | $410,000 | 0.00% |
| Balentine LLC | 55 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 177 | $0 | 0.00% |
| Vantage Investment Advisors, LLC | 1,150 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 5,453 | $7,000 | 0.00% |